Correction
5-Aza-Deoxycytidine Induces Selective Degradation of DNA Methyltransferase 1 by a Proteasomal Pathway That Requires the KEN Box, Bromo-Adjacent Homology Domain, and Nuclear Localization Signal
Paper Information
Record ID:
18099
Author(s):
Publication Date:
June 01, 2005
Retraction Date:
April 30, 2018
(7.6 years years ago)
Subjects:
Institution:
Department of Molecular and Cellular Biochemistry, College of Medicine, The Ohio State University, Columbus, OhioCountry:
🇺🇸 United StatesArticle Type:
Publisher:
American Society for Microbiology
Open Access:
Yes
PubMed ID:
Retraction PubMed ID:
Correction Details
Citations (386)
386
Total Citations111
Post-Retraction(28.8%)
270
Pre-Retraction0
Same DayPost-Retraction Citation Analysis
2
Within 30 days
22
Within 1 year
68
After 2+ years
2321
Days since retraction (latest)
Paper citing Physical and Functional Interaction of DNA Methylt...
Unknown Authors
Unknown Journal
Published: Unknown
Paper citing 5-Aza-Deoxycytidine Induces Selective Degradation ...
Unknown Authors
Unknown Journal
Published: Unknown
Paper citing 5-Aza-Deoxycytidine Induces Selective Degradation ...
Unknown Authors
Unknown Journal
Published: Unknown
Paper citing 5-Aza-Deoxycytidine Induces Selective Degradation ...
Unknown Authors
Unknown Journal
Published: Unknown
Paper citing 5-Aza-Deoxycytidine Induces Selective Degradation ...
Unknown Authors
Unknown Journal
Published: Unknown
Epigenetic-modifying agents: the potential game changers in the treatment of hematologic malignancies
Tahereh Hojjatipour, Mina Ajeli, Amirhosein Maali et al. (4 authors)
Critical Reviews in Oncology/Hematology
Published: Sep 2024
2 citations
2 citations
2321 days after retraction
Paper citing 5-Aza-Deoxycytidine Induces Selective Degradation ...
Unknown Authors
Unknown Journal
Published: Jul 2024
2276 days after retraction
Triptolide sensitizes cancer cells to nucleoside DNA methyltransferase inhibitors through inhibition of DCTPP1-mediated cell-intrinsic resistance
Jianyong Liu, Qingli He, Jianya Zhou et al. (25 authors)
bioRxiv (Cold Spring Harbor Laboratory)
Open Access
Published: May 2024
3 citations
3 citations
2213 days after retraction
Frequent loss of FAM126A expression in colorectal cancer results in selective FAM126B dependency
Shuang Li, Ting Han
iScience
Open Access
Published: Mar 2024
5 citations
5 citations
2160 days after retraction
Epigenetic causes of intellectual disability—the fragile X syndrome paradigm
Elisabetta Tabolacci, Giovanni Neri
Elsevier eBooks
Published: Jan 2024
1 citation
1 citation
2072 days after retraction
Nanomedicine and epigenome: Possible health risks, benefits, and future perspectives
Nitin Verma, Komal Thapa, Neha Kanojia et al. (6 authors)
Elsevier eBooks
Published: Jan 2024
2072 days after retraction
Non‐canonical nitric oxide signalling and DNA methylation: Inflammation induced epigenetic alterations and potential drug targets
Christopher Switzer
British Journal of Pharmacology
Open Access
Published: Dec 2023
5 citations
5 citations
2060 days after retraction
Epigenetic mechanisms of nicotine dependence
Caspar Muenstermann, Kelly J. Clemens
Neuroscience & Biobehavioral Reviews
Open Access
Published: Dec 2023
13 citations
13 citations
2047 days after retraction
Ectoine Globally Hypomethylates DNA in Skin Cells and Suppresses Cancer Proliferation
Majjid A. Qaria, Chunyan Xu, Ran Hu et al. (8 authors)
Marine Drugs
Open Access
Published: Nov 2023
7 citations
7 citations
2039 days after retraction
Histone Modifying Potential of Dietary Phytochemicals: Implications in Treating Breast Cancer
Aishwarya Laxmi, Sourbh Suren Garg, Arnika Singh et al. (5 authors)
Current Pharmacology Reports
Published: Sep 2023
1 citation
1 citation
1957 days after retraction
Inhibitors of UHRF1 base flipping activity showing cytotoxicity against cancer cells
Stefano Ciaco, Viola Mazzoleni, Aqib Javed et al. (8 authors)
Bioorganic Chemistry
Open Access
Published: May 2023
6 citations
6 citations
1848 days after retraction
The role of DNA methylation in ovarian cancer chemoresistance: A narrative review
Kaiyang Song, Mara Artibani
Health Science Reports
Open Access
Published: Apr 2023
7 citations
7 citations
1823 days after retraction
Efficacy of epigenetic agents for older patients with acute myeloid leukemia and myelodysplastic syndrome in randomized controlled trials: a systematic review and network meta-analysis
SuA Oh, Eun Young Kim
Clinical and Experimental Medicine
Published: Mar 2023
4 citations
4 citations
1790 days after retraction
Epigenetic Regulators of DNA Cytosine Modification: Promising Targets for Cancer Therapy
Inkyung Jung, Jungeun An, Myunggon Ko
Biomedicines
Open Access
Published: Feb 2023
7 citations
7 citations
1758 days after retraction
Targeting Epigenetic Mechanisms: A Boon for Cancer Immunotherapy
Asmita Parab, Lokesh Kumar Bhatt, Abdelwahab Omri
Biomedicines
Open Access
Published: Jan 2023
6 citations
6 citations
1715 days after retraction
Breast cancer epigenetics
Evanthia T. Roussos Torres, Roisín M. Connolly
Elsevier eBooks
Published: Jan 2023
1707 days after retraction
In the Pipeline: Emerging Therapy for MDS and MDS/MPN
Harinder Gill, Emily Lee, Pinky Mo
Unknown Journal
Published: Jan 2023
1707 days after retraction
The Genetic and Epigenetic Landscape of Cancer Stem Cells
Matthew Masoudi
Unknown Journal
Published: Jan 2023
1707 days after retraction
Epigenetic targets in B- and T-cell lymphomas: latest developments
Marcelo Lima Ribeiro, Salvador Sánchez-Vinces, Laura Mondragón et al. (4 authors)
Therapeutic Advances in Hematology
Open Access
Published: Jan 2023
2 citations
2 citations
1707 days after retraction
Recent progress in DNA methyltransferase inhibitors as anticancer agents
Zhixiong Zhang, Guan Wang, Yuyan Li et al. (8 authors)
Frontiers in Pharmacology
Open Access
Published: Dec 2022
74 citations
74 citations
1691 days after retraction
Contingent Synergistic Interactions between Non-Coding RNAs and DNA-Modifying Enzymes in Myelodysplastic Syndromes
Argiris Symeonidis, Theodora Chatzilygeroudi, Vasiliki Chondrou et al. (4 authors)
International Journal of Molecular Sciences
Open Access
Published: Dec 2022
5 citations
5 citations
1691 days after retraction
Is Induction of Hypomethylation with Ivosidenib and 5-Azacitidine Curative Regimen against IDH1-Mutated Acute Myeloid Leukemia?
Katsuhiko Takahashi
Anti-Cancer Agents in Medicinal Chemistry
Published: Dec 2022
1 citation
1 citation
1687 days after retraction
NNMT‐DNMT1 Axis is Essential for Maintaining Cancer Cell Sensitivity to Oxidative Phosphorylation Inhibition
Changqing Wu, Yue Liu, Wenju Liu et al. (18 authors)
Advanced Science
Open Access
Published: Nov 2022
32 citations
32 citations
1661 days after retraction
DNA methyltransferase-1 in acute myeloid leukaemia: beyond the maintenance of DNA methylation
Mengyuan Li, Donghua Zhang
Annals of Medicine
Open Access
Published: Jul 2022
13 citations
13 citations
1537 days after retraction
Novel Mechanisms for Post-Transplant Maintenance Therapy in Acute Myeloid Leukemia
Steven Manobianco, Tara Rakiewicz, Lindsay Wilde et al. (4 authors)
Frontiers in Oncology
Open Access
Published: Jul 2022
7 citations
7 citations
1534 days after retraction
Endothelial TET2 Regulates Cardiac Remodeling by Modifying Endothelial-to-Mesenchymal Transition
Wenxin Kou, Yefei Shi, Bo Li et al. (13 authors)
bioRxiv (Cold Spring Harbor Laboratory)
Open Access
Published: Jun 2022
1 citation
1 citation
1508 days after retraction
Metabolic and Epigenetic Regulation of SMAD7 by STC1 Ameliorates Lung Fibrosis
Shinya Ohkouchi, Masahiko Kanehira, Daisuke Saigusa et al. (16 authors)
American Journal of Respiratory Cell and Molecular Biology
Published: Jun 2022
9 citations
9 citations
1505 days after retraction
Pharmacologic Induction of BRCAness in BRCA-Proficient Cancers: Expanding PARP Inhibitor Use
Rachel Abbotts, Anna J. Dellomo, Feyruz V. Rassool
Cancers
Open Access
Published: May 2022
32 citations
32 citations
1487 days after retraction
Demethylation and Up-Regulation of an Oncogene after Hypomethylating Therapy
Yao‐Chung Liu, Junsu Kwon, Emiliano Fabiani et al. (27 authors)
New England Journal of Medicine
Open Access
Published: May 2022
45 citations
45 citations
1486 days after retraction
NOS2 and <i>S</i> -nitrosothiol signaling induces DNA hypomethylation and LINE-1 retrotransposon expression
Christopher Switzer, Hyun-Ju Cho, Thomas R. Eykyn et al. (5 authors)
Proceedings of the National Academy of Sciences
Open Access
Published: May 2022
19 citations
19 citations
1479 days after retraction
Environmentally induced DNA methylation is inherited across generations in an aquatic keystone species
Nathalie Feiner, Reinder Radersma, Louella Vasquez et al. (9 authors)
iScience
Open Access
Published: Apr 2022
25 citations
25 citations
1457 days after retraction
Epigenetic Anti‐Cancer Treatment With a Stabilized Carbocyclic Decitabine Analogue
Franziska R. Traube, Natércia F. Brás, Wynand P. Roos et al. (10 authors)
Chemistry - A European Journal
Open Access
Published: Mar 2022
5 citations
5 citations
1414 days after retraction
Glucagon signaling via supraphysiologic GCGR can reduce cell viability without stimulating gluconeogenic gene expression in liver cancer cells
Jason T. Godfrey, Romain Riscal, Nicolas Skuli et al. (4 authors)
Cancer & Metabolism
Open Access
Published: Feb 2022
3 citations
3 citations
1377 days after retraction
Epigenetic anti-cancer treatment with a stabilized carbocyclic Decitabine analogue
Franziska R. Traube, Natércia F. Brás, Wynand P. Roos et al. (10 authors)
bioRxiv (Cold Spring Harbor Laboratory)
Open Access
Published: Jan 2022
1363 days after retraction
Epigenetic Mediated Regulation of Cancer-Testis/Germline Antigen and Its Implication in Cancer Immunotherapy: A Treasure Map for Future Anticipatory Medicine
Rashmi Gupta, Bimal Prasad Jit, Ashok Sharma
Cognitive systems monographs
Published: Jan 2022
1 citation
1 citation
1342 days after retraction
Noncoding RNAs and Their Response Predictive Value in Azacitidine-treated Patients With Myelodysplastic Syndrome and Acute Myeloid Leukemia With Myelodysplasia-related Changes
Michaela Dostálová Merkerová, Jǐŕı Kléma, Dávid Kundrát et al. (11 authors)
Cancer Genomics & Proteomics
Open Access
Published: Jan 2022
7 citations
7 citations
1342 days after retraction
Small molecule targeting of chromatin writers in cancer
Andrew R. Conery, Jennifer L. Rocnik, Patrick Trojer
Nature Chemical Biology
Published: Dec 2021
29 citations
29 citations
1334 days after retraction
Environmentally-induced DNA methylation is inherited across generations in an aquatic keystone species (<i>Daphnia magna</i>)
Nathalie Feiner, Reinder Radersma, Louella Vasquez et al. (9 authors)
bioRxiv (Cold Spring Harbor Laboratory)
Open Access
Published: Dec 2021
3 citations
3 citations
1315 days after retraction
Zebularine induces enzymatic DNA–protein crosslinks in 45S rDNA heterochromatin of <i>Arabidopsis</i> nuclei
Klára Procházková, Andreas Finke, Eva Dvořák Tomaštíková et al. (9 authors)
Nucleic Acids Research
Open Access
Published: Dec 2021
10 citations
10 citations
1311 days after retraction
Epigenetic Signaling of Cancer Stem Cells During Inflammation
Zaoqu Liu, Yuqing Ren, Lingfang Meng et al. (9 authors)
Frontiers in Cell and Developmental Biology
Open Access
Published: Oct 2021
18 citations
18 citations
1264 days after retraction
Topoisomerase Assays
John L. Nitiss, Kostantin Kiianitsa, Yilun Sun et al. (5 authors)
Current Protocols
Open Access
Published: Oct 2021
22 citations
22 citations
1250 days after retraction
Resistance to Hypomethylating Agents in Myelodysplastic Syndrome and Acute Myeloid Leukemia From Clinical Data and Molecular Mechanism
Guangjie Zhao, Qian Wang, S. Li et al. (4 authors)
Frontiers in Oncology
Open Access
Published: Sep 2021
19 citations
19 citations
1247 days after retraction
5-Aza-4′-thio-2′-deoxycytidine, a New Orally Bioavailable Nontoxic “Best-in-Class”: DNA Methyltransferase 1–Depleting Agent in Clinical Development
William B. Parker, Jaideep V. Thottassery
Journal of Pharmacology and Experimental Therapeutics
Open Access
Published: Sep 2021
18 citations
18 citations
1228 days after retraction
Effect of Decitabine (5-aza-2ˈ-deoxycytidine, 5-aza-CdR) in Comparison with Vorinostat (Suberoylanilide Hydroxamic Acid, SAHA) on DNMT1, DNMT3a and DNMT3b, HDAC 1-3, SOCS 1, SOCS 3, JAK2, and STAT3 Gene Expression in Hepatocellular Carcinoma HLE and LCL-PI 11 Cell Lines
Masumeh Sanaei, Fraidoon Kavoosi, Mohammad Pourahmadi
Asian Pacific Journal of Cancer Prevention
Open Access
Published: Jul 2021
9 citations
9 citations
1158 days after retraction
Anti-neoplastic and demethylating activity of a newly synthetized flavanone-derived compound in Renal Cell Carcinoma cell lines
Ângela Marques-Magalhães, Inês Graça, Vera Miranda‐Gonçalves et al. (7 authors)
Biomedicine & Pharmacotherapy
Open Access
Published: Jun 2021
4 citations
4 citations
1142 days after retraction
Related Records
This article has multiple records in the database due to different notices:
Record #36485
Apr 12, 2022Quick Stats
Total Citations:
386
Years Since Retraction:
7.6 years
Open Access:
Yes
Last Checked:
Never